• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor.环氧补骨脂素对巨噬细胞移动抑制因子的抗炎新活性:抑制巨噬细胞移动抑制因子的互变异构酶和促炎活性。
J Biol Chem. 2012 Jul 13;287(29):24844-61. doi: 10.1074/jbc.M112.341321. Epub 2012 May 29.
2
ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.ISO-1与巨噬细胞迁移抑制因子的互变异构酶活性位点结合,可抑制其促炎活性并提高严重脓毒症的生存率。
J Biol Chem. 2005 Nov 4;280(44):36541-4. doi: 10.1074/jbc.C500243200. Epub 2005 Aug 22.
3
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.合成并评价人巨噬细胞移动抑制因子抑制剂以开发抗炎药物。
Bioorg Med Chem. 2011 Dec 15;19(24):7365-73. doi: 10.1016/j.bmc.2011.10.056. Epub 2011 Oct 24.
4
Elevated levels of the Plasmodium yoelii homologue of macrophage migration inhibitory factor attenuate blood-stage malaria.疟原虫巨噬细胞移动抑制因子同源物水平升高可减轻疟原虫血症。
Infect Immun. 2010 Dec;78(12):5151-62. doi: 10.1128/IAI.00277-10. Epub 2010 Sep 13.
5
Obacunone causes sustained expression of MKP-1 thus inactivating p38 MAPK to suppress pro-inflammatory mediators through intracellular MIF.Obacunone 通过细胞内 MIF 引起 MKP-1 的持续表达,从而使 p38 MAPK 失活,以抑制促炎介质。
J Cell Biochem. 2018 Jan;119(1):837-849. doi: 10.1002/jcb.26248. Epub 2017 Aug 3.
6
Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host.裂殖疟原虫 MIF 同源物与宿主鼠类 MIF 的结构和功能比较。
Mol Immunol. 2010 Jan;47(4):726-37. doi: 10.1016/j.molimm.2009.10.037. Epub 2009 Dec 8.
7
Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.巨噬细胞移动抑制因子通过促进核因子-κB 的激活来调节白细胞介素-6 的产生,从而在创伤弧菌感染期间发生。
BMC Immunol. 2010 Oct 12;11:50. doi: 10.1186/1471-2172-11-50.
8
Macrophage migration inhibitory factor contributes to immunopathogenesis during 17XL infection.巨噬细胞移动抑制因子在 17XL 感染期间有助于免疫发病机制。
Front Cell Infect Microbiol. 2022 Aug 24;12:968422. doi: 10.3389/fcimb.2022.968422. eCollection 2022.
9
Synthesis and evaluation of anti-plasmodial and cytotoxic activities of epoxyazadiradione derivatives.环氧法尼醇衍生物的合成及抗疟和细胞毒性活性评价。
Eur J Med Chem. 2017 Jul 7;134:242-257. doi: 10.1016/j.ejmech.2017.04.016. Epub 2017 Apr 13.
10
Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.迁移抑制因子诱导巨噬细胞杀伤硕大利什曼原虫:依赖于活性氮中间体和内源性肿瘤坏死因子-α。
J Immunol. 1998 Sep 1;161(5):2383-90.

引用本文的文献

1
Prenatal Exposure to Azadiradione Leads to Developmental Disabilities.孕期接触印苦楝酮会导致发育障碍。
Mol Neurobiol. 2025 Mar;62(3):3601-3614. doi: 10.1007/s12035-024-04493-x. Epub 2024 Sep 23.
2
Therapeutic Opportunities in Breast Cancer by Targeting Macrophage Migration Inhibitory Factor as a Pleiotropic Cytokine.通过靶向巨噬细胞移动抑制因子这一多功能细胞因子探索乳腺癌的治疗新机遇
Breast Cancer (Auckl). 2024 Sep 6;18:11782234241276310. doi: 10.1177/11782234241276310. eCollection 2024.
3
Nimbolide: promising agent for prevention and treatment of chronic diseases (recent update).印楝素:预防和治疗慢性病的有前景药物(最新进展)。
Food Nutr Res. 2024 Mar 18;68. doi: 10.29219/fnr.v68.9650. eCollection 2024.
4
Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke.细胞坏死性凋亡:神经退行性疾病和中风中的机制、调节及治疗前景。
Biochem Pharmacol. 2024 Oct;228:116174. doi: 10.1016/j.bcp.2024.116174. Epub 2024 Mar 27.
5
Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome.间质性膀胱炎/膀胱疼痛综合征中的氧化应激机制。
Nat Rev Urol. 2024 Jul;21(7):433-449. doi: 10.1038/s41585-023-00850-y. Epub 2024 Feb 7.
6
Application of the herbal chemical marker ranking system (Herb MaRS) to the standardization of herbal raw materials: a case study.草药化学标志物等级系统(Herb MaRS)在草药原料标准化中的应用:案例研究。
BMC Complement Med Ther. 2023 Sep 30;23(1):348. doi: 10.1186/s12906-023-04178-3.
7
Effects of molecular weight on intestinal anti-inflammatory activities of β-D-glucan from .分子量对源自……的β-D-葡聚糖肠道抗炎活性的影响
Front Nutr. 2022 Sep 29;9:1028727. doi: 10.3389/fnut.2022.1028727. eCollection 2022.
8
Ultra-high performance liquid chromatography Q-Orbitrap MS/MS-based profiling and quantification of limonoids in Meliaceae plants.基于超高效液相色谱-四极杆-Orbitrap 串联质谱的桃金娘科植物中柠檬苦素类成分的分析及定量
Anal Bioanal Chem. 2022 Aug;414(20):6093-6106. doi: 10.1007/s00216-022-04169-2. Epub 2022 Jun 21.
9
Bladder Oxidative Stress and HMGB1 Release Contribute to PAR4-Mediated Bladder Pain in Mice.膀胱氧化应激和高迁移率族蛋白B1释放促成小鼠PAR4介导的膀胱疼痛。
Front Syst Neurosci. 2022 May 13;16:882493. doi: 10.3389/fnsys.2022.882493. eCollection 2022.
10
Anti-Inflammatory Medicinal Plants of Bangladesh-A Pharmacological Evaluation.孟加拉国的抗炎药用植物——药理学评价
Front Pharmacol. 2022 Mar 24;13:809324. doi: 10.3389/fphar.2022.809324. eCollection 2022.

本文引用的文献

1
Macrophage migration inhibitory factor in protozoan infections.原生动物感染中的巨噬细胞移动抑制因子
J Parasitol Res. 2012;2012:413052. doi: 10.1155/2012/413052. Epub 2012 Feb 9.
2
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.合成并评价人巨噬细胞移动抑制因子抑制剂以开发抗炎药物。
Bioorg Med Chem. 2011 Dec 15;19(24):7365-73. doi: 10.1016/j.bmc.2011.10.056. Epub 2011 Oct 24.
3
Identification and molecular characterization of an Alba-family protein from human malaria parasite Plasmodium falciparum.鉴定和分子特征分析人类疟原虫 Plasmodium falciparum 中的 Alba 家族蛋白。
Nucleic Acids Res. 2012 Feb;40(3):1174-90. doi: 10.1093/nar/gkr821. Epub 2011 Oct 17.
4
[Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma].巨噬细胞移动抑制因子在膀胱尿路上皮癌中的表达及意义
Zhonghua Zhong Liu Za Zhi. 2011 Jan;33(1):28-31.
5
Characterization, epitope identification and mechanisms of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor.鉴定单克隆抗巨噬细胞移动抑制因子的杀菌能力、表位识别及作用机制。
Int Immunopharmacol. 2011 Sep;11(9):1333-40. doi: 10.1016/j.intimp.2011.04.017. Epub 2011 May 13.
6
Anti-inflammatory effect of the water fraction from hawthorn fruit on LPS-stimulated RAW 264.7 cells.山楂水提物对 LPS 刺激的 RAW264.7 细胞的抗炎作用。
Nutr Res Pract. 2011 Apr;5(2):101-6. doi: 10.4162/nrp.2011.5.2.101. Epub 2011 Apr 23.
7
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor.
Cytokine. 2011 Aug;55(2):165-7. doi: 10.1016/j.cyto.2011.03.027. Epub 2011 May 7.
8
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.巨噬细胞移动抑制因子的 HLA 呈递片段是侵袭性乳腺癌的治疗靶点。
J Immunol. 2011 Jun 1;186(11):6607-16. doi: 10.4049/jimmunol.1003995. Epub 2011 Apr 22.
9
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.MIF 作为疾病靶点:ISO-1 作为概念验证治疗方法。
Future Med Chem. 2011 Jan;3(1):45-63. doi: 10.4155/fmc.10.281.
10
Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.巨噬细胞移动抑制因子和 CD74 通过 MAPK 和 Rho GTPase 调节巨噬细胞趋化反应。
J Immunol. 2011 Apr 15;186(8):4915-24. doi: 10.4049/jimmunol.1003713. Epub 2011 Mar 16.

环氧补骨脂素对巨噬细胞移动抑制因子的抗炎新活性:抑制巨噬细胞移动抑制因子的互变异构酶和促炎活性。

Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor.

机构信息

Division of Infectious Diseases and Immunology, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, West Bengal, India.

出版信息

J Biol Chem. 2012 Jul 13;287(29):24844-61. doi: 10.1074/jbc.M112.341321. Epub 2012 May 29.

DOI:10.1074/jbc.M112.341321
PMID:22645149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3397911/
Abstract

Macrophage migration inhibitory factor (MIF) is responsible for proinflammatory reactions in various infectious and non-infectious diseases. We have investigated the mechanism of anti-inflammatory activity of epoxyazadiradione, a limonoid purified from neem (Azadirachta indica) fruits, against MIF. Epoxyazadiradione inhibited the tautomerase activity of MIF of both human (huMIF) and malaria parasites (Plasmodium falciparum (PfMIF) and Plasmodium yoelii (PyMIF)) non-competitively in a reversible fashion (K(i), 2.11-5.23 μm). Epoxyazadiradione also significantly inhibited MIF (huMIF, PyMIF, and PfMIF)-mediated proinflammatory activities in RAW 264.7 cells. It prevented MIF-induced macrophage chemotactic migration, NF-κB translocation to the nucleus, up-regulation of inducible nitric-oxide synthase, and nitric oxide production in RAW 264.7 cells. Epoxyazadiradione not only exhibited anti-inflammatory activity in vitro but also in vivo. We tested the anti-inflammatory activity of epoxyazadiradione in vivo after co-administering LPS and MIF in mice to mimic the disease state of sepsis or bacterial infection. Epoxyazadiradione prevented the release of proinflammatory cytokines such as IL-1α, IL-1β, IL-6, and TNF-α when LPS and PyMIF were co-administered to BALB/c mice. The molecular basis of interaction of epoxyazadiradione with MIFs was explored with the help of computational chemistry tools and a biological knowledgebase. Docking simulation indicated that the binding was highly specific and allosteric in nature. The well known MIF inhibitor (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1) inhibited huMIF but not MIF of parasitic origin. In contrast, epoxyazadiradione inhibited both huMIF and plasmodial MIF, thus bearing an immense therapeutic potential against proinflammatory reactions induced by MIF of both malaria parasites and human.

摘要

巨噬细胞移动抑制因子(MIF)负责各种感染性和非感染性疾病的促炎反应。我们研究了从印楝(Azadirachta indica)果实中分离出的一种单萜环氧角鲨烯抑制 MIF 的抗炎活性的机制。环氧角鲨烯以非竞争性和可逆的方式抑制人类(huMIF)和疟原虫(Plasmodium falciparum(PfMIF)和 Plasmodium yoelii(PyMIF))MIF 的互变异构酶活性(K(i),2.11-5.23 μm)。环氧角鲨烯还显著抑制 RAW 264.7 细胞中 MIF(huMIF、PyMIF 和 PfMIF)介导的促炎活性。它阻止 MIF 诱导的巨噬细胞趋化迁移、NF-κB 向核内易位、诱导型一氧化氮合酶的上调和 RAW 264.7 细胞中的一氧化氮产生。环氧角鲨烯不仅在体外表现出抗炎活性,而且在体内也表现出抗炎活性。我们在小鼠中同时给予 LPS 和 MIF 以模拟败血症或细菌感染的疾病状态,测试了环氧角鲨烯的抗炎活性。环氧角鲨烯阻止了促炎细胞因子如 IL-1α、IL-1β、IL-6 和 TNF-α的释放,当 LPS 和 PyMIF 同时给予 BALB/c 小鼠时。借助计算化学工具和生物知识库,探讨了环氧角鲨烯与 MIFs 相互作用的分子基础。对接模拟表明,结合具有高度特异性和变构性质。众所周知的 MIF 抑制剂(S,R)-3-(4-羟基苯基)-4,5-二氢-5-异恶唑乙酸甲酯(ISO-1)抑制 huMIF,但不抑制寄生虫来源的 MIF。相比之下,环氧角鲨烯抑制 huMIF 和疟原虫 MIF,因此对疟原虫和人类的 MIF 引起的促炎反应具有巨大的治疗潜力。